Bowel cancer medication could help combat early-onset Parkinson’s disease
People with certain forms of early-onset Parkinson’s disease could potentially benefit from taking a medication used to treat certain forms of cancer.
List view / Grid view
People with certain forms of early-onset Parkinson’s disease could potentially benefit from taking a medication used to treat certain forms of cancer.
Charles River Laboratories today announced that it has extended its longstanding, strategic, integrated drug discovery partnership with Chiesi Farmaceutici SpA in the field of respiratory disease...
A new study has identified a previously undescribed role for a type of unconventional T cell with the potential to be used in the development of new therapies for infection and cancer.
Umeå researchers have created datasets that map the three-dimensional distribution and volume of the insulin-producing cells in the pancreas.
SMi Group have released a series of interviews ahead of the industry gathering on pain management, Pain Therapeutics 2017.
Sanofi and Lonza have entered into a strategic partnership to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland.
Pfizer currently undertakes studies on healthy volunteers on two floors of the existing Erasme One-Day Hospital in the Brussels region, Belgium. To increase capacity, Pfizer’s original office and volunteers screening area has been divided into two separate units: one office and screening area outside the hospital for ambulatory visits, and…
Research in zebrafish opens up new ideas for therapies for blinding diseases
Myosin provides model for nanomachines
Cannabidiol shown to affect emotion and emotional memory
KL4 could improve efficiency in stem cell generation
Vitamin C is up to ten times more effective at stopping cancer cell growth than pharmaceuticals such as 2-DG, according to an article published in Oncotarget
A new research programme has been launched to produce all the human secreted proteins in mammalian cell factories. The programme aims to facilitate studies of this important class of proteins, which are involved in many human diseases.
How do tumours grow? And how do bacteria transform harmless substances into medical agents? When biophysicists want to understand what is happening in living cells, they have to introduce fluorescent probes or other foreign molecules. There are several ways to overcome the cell wall without causing the cell permanent harm.
Believed by many to be a relic of past centuries, tuberculosis (TB) causes more deaths than any other infectious disease including HIV/AIDs. In 2015 there were an estimated 10.4 million new cases of TB and 1.4 million deaths from the disease.